Interstitial Lung Disease Due to Systemic Disease (Disorder): Clinical Trials

7 trials for Interstitial Lung Disease Due to Systemic Disease (Disorder), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 active not recruiting, 1 completed, 1 enrolling by invitation. 1 Not applicable, 1 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable1Enrolling by invitation 1
Phase 31Completed 1
Phase 41Terminated 1

Follow Interstitial Lung Disease Due to Systemic Disease (Disorder): new trials by email Literature Review of Interstitial Lung Disease Due to Systemic Disease (Disorder) trials Research Report on Interstitial Lung Disease Due to Systemic Disease (Disorder)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Occupational and Environmental Exposures Analysis in Interstitial Lung Diseases.
standard interview - Interstitial Lung Disease Due to Systemic Disease (Disorder), Interstitial Lung Disease Due to Systemic Disease (Telomere Biology Disorder)
Active not recruitingIstituto Clinico Humanitas10002026-04-012026-05-11
Teleconsultation Approach to CTD-ILD Care Delivery in Rural UnderServed CommuniTies (TRUST Initiative)
Interstitial Lung Disease Due to Systemic Disease (Disorder), Interstitial Lung Disease in Patients With Rheumatoid Arthritis
Not yet recruitingSt. Lawrence Health System102025-11-012025-10-15
Radiologic Features of Rheumatoid Arthritis Interstitial Lung Disease at Chest High Resolution Computed Tomography
High resolution computed tomography - Reumatoid Arthritis, Interstitial Lung Disease Due to Systemic Disease (Disorder)
RecruitingAzienda Unita Sanitaria Locale di Piacenza5002025-01-082025-09-15
AYLo - AutoimmunitY and Loss of y
Single nucleotide polymorphisms (SNP), 3'mRNA sequencing, Enzyme-linked immunosorbent assay (ELISA) and Legendplex Array - Giant Cell Arteritis (GCA), Polymyalgia Rheumatica (PMR)
RecruitingUniversity of Bonn5002024-11-152025-04-10
Physical Exercise Program for Adults With Diffuse Interstitial Lung Disease in a Pulmonary Rehabilitation Context
Aerobic excersise, Muscle strength limbs, inspiratory muscle strength - Interstitial Lung Disease Due to Systemic Disease (Disorder), Interstitial Lung Disease in Patients With Rheumatoid Arthritis
Not applicableEnrolling by invitationUniversidad de La Frontera292024-10-012025-07-11
Use of Selective JAK Inhibitor in ILD and Skin Tightness of Systemic Sclerosis Versus MMF
Upadacitinib 15 MG, Cellcept Oral Product - Interstitial Lung Disease Due to Systemic Disease (Disorder)
Phase 3CompletedAssiut University602023-01-152025-01-06
Effects of Tofacitinib vs Methotrexate on Rheumatoid Arthritis Interstitial Lung Disease
Tofacitinib, Methotrexate - Rheumatoid Arthritis, Interstitial Lung Disease Due to Systemic Disease (Disorder)
Phase 4TerminatedVastra Gotaland Region32020-11-072024-05-23

Narrower conditions

Lung Diseases, Interstitial (4)  ·  Arthritis, Rheumatoid (3)  ·  Connective Tissue Diseases (2)  ·  Idiopathic Pulmonary Fibrosis (2)  ·  Alveolitis, Extrinsic Allergic (1)  ·  Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (1)  ·  Arthritis, Psoriatic (1)  ·  Autoimmune Diseases (1)  ·  Giant Cell Arteritis (1)  ·  Immunoglobulin G4-Related Disease (1)  ·  Myositis (1)  ·  Polymyalgia Rheumatica (1)  ·  Pulmonary Disease, Chronic Obstructive (1)  ·  Pulmonary Fibrosis (1)  ·  Sarcoidosis (1)

Broader conditions

Lung Diseases (5)  ·  Respiratory Tract Diseases (5)  ·  Immune System Diseases (4)  ·  Arthritis (3)  ·  Joint Diseases (3)  ·  Musculoskeletal Diseases (3)  ·  Rheumatic Diseases (3)  ·  Skin and Connective Tissue Diseases (3)  ·  Autoimmune Diseases (2)  ·  Hypersensitivity (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Pulmonary Fibrosis (2)  ·  Arteritis (1)  ·  Autoimmune Diseases of the Nervous System (1)

Interventions

Flow Cytometry (1)  ·  Methotrexate (1)  ·  Polymorphism, Single Nucleotide (1)  ·  tofacitinib (1)  ·  upadacitinib (1)

Sponsors

Assiut University (1)  ·  Azienda Unita Sanitaria Locale di Piacenza (1)  ·  Istituto Clinico Humanitas (1)  ·  St. Lawrence Health System (1)  ·  Universidad de La Frontera (1)  ·  University of Bonn (1)  ·  Vastra Gotaland Region (1)

Countries

Italy (2)  ·  Chile (1)  ·  Czechia (1)  ·  Egypt (1)  ·  Germany (1)  ·  Sweden (1)  ·  United States (1)

Top investigators

Anna-Karin H Ekwall, MD MSc PhD (1)  ·  Francesco Amati, MD (1)  ·  Manal Hassanien, professor (1)

Results publications

PMID 26025176, PMID 34024401